Atherosclerosis and related cardiovascular diseases represent one of the greatest threats to human health worldwide. Despite important progress in prevention and treatment, these conditions still ...

In mice trial, experimental nanovaccine found to reduce development of condition that can lead to blood clots, stroke and ...

CD8+ T cells accumulate in atherosclerotic plaques. LMU researchers identify a crucial signaling pathway – with therapeutic potential.

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Germans Trias i Pujol Research Institute (IGTP) have studied variations in mRNA length during the progression of ...

CD8+ T cells accumulate in atherosclerotic plaques. LMU researchers identify a crucial signaling pathway—with therapeutic ...

Prior to 1990, many assumed that once cholesterol plaques form in the arteries causing atherosclerosis, it was not reversible. While this is true for plaques that have calcified, what about ...

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Germans Trias i Pujol Research Institute (IGTP ...

Get Instant Summarized Text (Gist) Kanglexin (KLX), an anthraquinone compound, shows potential in treating atherosclerosis by inhibiting endothelial-to-mesenchymal transition (EndMT). KLX targets ...